A
$ Value
$0
Shares
75,000
Price
$0
Filed
Feb 13
Insider
Name
ALAM JOHN J
Title
CEO & President
CIK
0001197014
Roles
Director
Officer
10% Owner
Transaction Details
Transaction Date
2026-02-11
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
75,000
Footnotes
The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026.
Filing Info
ALAM JOHN J's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | CRVO | A | $0 |
| 2025-11-17 | CRVO | ▲ | $91K ★ |
| 2025-11-17 | CRVO | ▲ | $91K |
| 2025-11-14 | CRVO | ▲ | $13K |
| 2025-11-14 | CRVO | ▲ | $13K |
| 2025-11-13 | CRVO | ▲ | $33K |
| 2025-11-12 | CRVO | ▲ | $41K |
| 2025-06-23 | CRVO | A | $0 |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Gregoire Sylvie | — | — | 2026-02-11 |
|
Blackburn Kelly
EVP, Clinical Development
|
— | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |